Browse by Audience
Skip to content
Papers of the Week
Dinutuximab in adult-onset chemotherapy refractory high-risk neuroblastoma.
Authors
Abstract
Neuroblastoma is the most common extracranial solid tumor in pediatrics but is considerably uncommon in adults, with approximately 1 case per 10 million diagnosed per year and is associated with poor prognosis. There are no standard treatment protocols for adult-onset neuroblastomas and there are only a few published case reports on neuroblastoma in adults.